(8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide
C20H28N2O3 — CID 124627825
Data last refreshed: (MolForge compound catalog, from PubChem)
About (8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide
(8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide (PubChem CID 124627825) has the molecular formula C20H28N2O3 and a molecular weight of 344.46 g/mol. Its IUPAC name is (8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide.
Molecular Properties
| Compound Name | (8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide |
|---|---|
| PubChem CID | 124627825 |
| Molecular Formula | C20H28N2O3 |
| Molecular Weight | 344.46 g/mol |
| Exact Mass | 344.21 |
| IUPAC Name | (8R)-N-[[(3R)-8-methyl-1,4-dioxaspiro[4.5]decan-3-yl]methyl]-5,6,7,8-tetrahydroquinoline-8-carboxamide |
| SMILES | CC1CCC2(CC1)OC[C@@H](CNC(=O)[C@@H]1CCCc3cccnc31)O2 |
| InChI | InChI=1S/C20H28N2O3/c1-14-7-9-20(10-8-14)24-13-16(25-20)12-22-19(23)17-6-2-4-15-5-3-11-21-18(15)17/h3,5,11,14,16-17H,2,4,6-10,12-13H2,1H3,(H,22,23)/t14?,16-,17-,20?/m1/s1 |
| InChIKey | QQDMZFUPGMWQQU-SXOSEBPOSA-N |
| XLogP | 2.94 |
| TPSA | 60.45 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 344.46 |
| LogP ≤ 5 | 2.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124627825 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.